CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B309. A total of 32 filers reported holding CAPRICOR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,009,157 | +107.9% | 295,075 | +190.6% | 0.00% | – |
| Q2 2023 | $485,337 | +18.7% | 101,535 | +4.8% | 0.00% | – |
| Q1 2023 | $408,994 | -65.5% | 96,918 | -68.5% | 0.00% | – |
| Q4 2022 | $1,186,834 | -52.1% | 307,470 | -25.6% | 0.00% | – |
| Q3 2022 | $2,480,000 | +53.2% | 413,231 | -10.9% | 0.00% | – |
| Q2 2022 | $1,619,000 | -1.0% | 463,937 | -2.7% | 0.00% | – |
| Q1 2022 | $1,636,000 | -35.8% | 476,662 | -45.2% | 0.00% | – |
| Q4 2021 | $2,548,000 | -11.3% | 870,002 | +21.7% | 0.00% | – |
| Q3 2021 | $2,874,000 | +17.1% | 714,965 | +49.5% | 0.00% | – |
| Q2 2021 | $2,454,000 | +16.0% | 478,345 | +5.8% | 0.00% | – |
| Q1 2021 | $2,115,000 | -31.4% | 452,026 | -49.7% | 0.00% | – |
| Q4 2020 | $3,082,000 | -4.0% | 899,106 | +47.0% | 0.00% | – |
| Q3 2020 | $3,212,000 | +301.5% | 611,736 | +251.9% | 0.00% | – |
| Q2 2020 | $800,000 | – | 173,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,166,249 | $5,983,000 | 0.82% |
| GSA CAPITAL PARTNERS LLP | 112,364 | $576,000 | 0.06% |
| Coastal Bridge Advisors, LLC | 10,894 | $56,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,302 | $73,000 | 0.00% |
| Cutler Group LLC / CA | 8,286 | $42,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 16,500 | $85,000 | 0.00% |
| Cutler Group LLC / CA | 9,700 | $13,000 | 0.00% |
| HAP Trading, LLC | 21,100 | $36,000 | 0.00% |
| JANE STREET GROUP, LLC | 23,400 | $120,000 | 0.00% |
| UBS Group AG | 1,922 | $10,000 | 0.00% |